Home » Indian Pharma Dominates Drug Master Filings in US
Indian Pharma Dominates Drug Master Filings in US
Indian pharma companies dominated the DMF (drug master filing) space with 74 filings, accounting for 37% share of the total. A total of 198 DMFs, primarily Type I and II, were filed with the US food and drug administration, according to the latest DMF list for quarter ended March 2005. A total of 74 filings were divided among 25 companies from India.
()a href="http://www.financialexpress.com/fe_full_story.php?content_id=93074" target="_blank">The Financial Express
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May